Abstract:
Purpose: Research of
legislation and
highlight the
peculiarities of
pharmaceutical
control in the
countries of
the EU, CIS,.
Southeast Asia. Results: Pharmaceutical control. The European Medicines
Agency (EMA) is a
decentralised agency of the
European Union (EU)
responsible for the scientific
evaluation, supervision and
safety monitoring of medicines
in the EU medicines.
To fulfill its mission, the
European Medicines Agency
(EMA) works closely
with national competent
authorities in a regulatory
network. The Agency also
implements policies and
procedures to ensure it works
independently, openly and
transparently and support the
highest standards in its
scientific recommendations. In the Commonwealth of
Independent States (CIS)
countries the pharmaceutical
control function is a
component part of the
Ministries of Health, or there
are special departments. The
Council of the Eurasian
Economic Commission (RUS,
BLR, KAZ, ARM, KGZ)
approved a single decision to
conduct pharmaceutical
inspections. Thus the
inspection is carried out by a
pharmaceutical inspectorate
on the basis of an inspection
plan, an inspection request
or at the request of an
authorized body of a
Member State. All countries in the Southeast
Asia (SEA) region have a shortage
of drug insurance for the
population. Although progress
has been made, challenges
remain in delivering the right
drugs at the right time.
National regulatory agencies
(NRAs) protect public health by
ensuring the efficacy, safety and
quality of medicines, but with the
development of the
pharmaceutical market, financial
and human resources are often
limited. Thus, some NRAs may
legitimately decide to rely on
other competent regulatory
authorities to fulfill Pharmaceutical control has a
common goal regardless of the
country, namely ensuring the quality
of the drug at all stages: production,
distribution, up to marketing in
pharmacies and use by the patient. National medicines policies and laws
are the basis for good governance
and coordination in the
pharmaceutical sector. An effective
national drug policy establishes the
state's commitment to ensuring
equitable access to effective, safe
and quality medicines.
Description:
Department of Social Pharmacy “Vasile Procopisin”, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltare
